ARTICLE | Clinical News
LCT preclinical data
April 11, 2005 7:00 AM UTC
In a monkey model of diabetes, DiaBCell encapsulated living islet cells treatment led to a reduction in insulin dose as compared to an increase in the control group (p=0.0002). The encapsulated living...